ArticleInflammopharmacology2023

A low dose of naloxone mitigates autoimmune hepatitis by regulating TLR4/NF-κB and Nrf2/HO-1 signaling pathways.

Kawther Magdy Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.